Drug facts
MoleculePantoprazole (Protonix)
Generics already compete: 30 makers on the market. 43 A-rated products from 30 makers substitute at the counter.
Protonix was first approved by the FDA on 02/02/2000 under NDA 020987; the application holder is Wyeth Pharmaceuticals LLC.
The latest NADAC for PANTOPRAZOLE SOD DR 20 MG TAB is $0.04 per unit (as of 10/28/2026).
Holder Wyeth Pharmaceuticals LLCApplication NDA 020987Approved 02/02/2000
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No NDA 020987 patent listed in the Orange Book Orange Book
- Later patents, other products
- Protonix (NDA 022020) 12/07/2026 Orange Book
02Competition
- Generics
- 30 generic makers Orange Book
- First generic approved
- 08/02/2007 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Pantoprazole profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $0.04 per unitPANTOPRAZOLE SOD DR 20 MG TAB, as of 10/28/2026 CMS NADAC
- Latest recall
- 08/06/2026Class II, Pantoprazole Sodium in 0.9% Sodium Chloride, Baxter Healthcare Corporation FDA enforcement
04Product
- Application holder
- Wyeth Pharmaceuticals LLC Orange Book
- Application
- NDA 020987 Orange Book
- First approved
- 02/02/2000 Orange Book
- Dosage forms
- for suspension, delayed release; injectable; powder; solution; tablet, delayed release
- Routes
- intravenous, oral
- Other brand names
- Protonix IV
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.